RARRES1 antibody (C-Term)
Quick Overview for RARRES1 antibody (C-Term) (ABIN657062)
Target
See all RARRES1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 134-163, C-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This RARRES1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 134-163 amino acids from the C-terminal region of human RARRES1.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- WB: 1:1000. IHC-P: 1:10~50
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Expiry Date
- 6 months
-
-
- RARRES1 (Retinoic Acid Receptor Responder (Tazarotene Induced) 1 (RARRES1))
-
Alternative Name
- RARRES1
-
Background
- This gene was identified as a retinoid acid (RA) receptor-responsive gene. It encodes a type 1 membrane protein. The expression of this gene is upregulated by tazarotene as well as by retinoic acid receptors. The expression of this gene is found to be downregulated in prostate cancer, which is caused by the methylation of its promoter and CpG island. Alternatively spliced transcript variant encoding distinct isoforms have been observed.
-
Molecular Weight
- 33285
-
NCBI Accession
- NP_002879, NP_996846
-
UniProt
- P49788
Target
-